Edith Mitchell
Medical Oncology · Philadelphia, PANPI 1639191984
Payments from drug & device makers
Across 177 payments — averaging $3122.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Taiho Oncology, Inc.$319K
- Genentech, Inc.$59K
- AbbVie$23K
- E.r. Squibb & Sons, L.L.C.$20K
- Merck$16K
- Ipsen Biopharmaceuticals, Inc$15K
- plus $99K from 20 others
Across 6 payments — averaging $3783.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$18K
- Pfizer$4K
- F. Hoffmann-la Roche AG$1K
What the payments were for
- Consulting fees$138,87863%
- Speaking & faculty fees$60,58927%
- Grants$1,8801%
- Travel & lodging$14,0176%
- Food & beverage$5,0672%
- Education$330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Taiho Oncology, Inc. | 19 | $319,474 |
| Genentech, Inc. | 19 | $59,423 |
| AbbVie | 2 | $22,850 |
| E.r. Squibb & Sons, L.L.C. | 8 | $19,717 |
| Merck | 14 | $16,376 |
| Ipsen Biopharmaceuticals, Inc | 12 | $15,428 |
| Pfizer | 8 | $13,624 |
| Genentech USA, Inc. | 14 | $13,091 |
| Exelixis Inc. | 21 | $12,101 |
| Gilead | 4 | $10,588 |
| Bristol Myers Squibb | 8 | $10,438 |
| Janssen Research & Development, LLC | 18 | $8,149 |
| AstraZeneca | 1 | $6,508 |
| Array Biopharma Inc | 2 | $5,179 |
| Labcorp Holdings Inc. | 3 | $4,363 |
| GSK | 2 | $3,900 |
| Regeneron | 4 | $3,414 |
| G1 Therapeutics, Inc. | 3 | $2,699 |
| Bayer | 3 | $2,342 |
| Sanofi | 1 | $1,880 |
| Daiichi Sankyo Inc. | 6 | $504 |
| Foundation Medicine, Inc. | 1 | $229 |
| Angiodynamics, Inc. | 1 | $192 |
| Johnson & Johnson | 1 | $100 |
| Roche Molecular Systems, Inc. | 1 | $97 |
| Lilly USA, LLC | 1 | $68 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$552,734 in reported general payments places this provider in the 70th percentile of 238 medical oncology providers in Pennsylvania.
Other medical oncology in Philadelphia
- Sukhmani PaddaPhiladelphia$25.6M
- Peter O DwyerPhiladelphia$18M
- Margaret von MehrenPhiladelphia$17.4M
- Kim Reiss BinderPhiladelphia$16.9M
- Carl JunePhiladelphia$13M
- Takami SatoPhiladelphia$11.5M
- Vivek NarayanPhiladelphia$10.6M
- Ubaldo Martinez-OutschoornPhiladelphia$10.5M
- Neil PalmisianoPhiladelphia$10.1M
- Anthony OlszanskiPhiladelphia$9.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.